How much is a share of GSK worth?
One share of GSK stock can currently be purchased for approximately $44.10. How much money does GlaxoSmithKline make? GlaxoSmithKline has a market capitalization of $118.74 billion and generates $43.79 billion in revenue each year.
What is the ticker symbol for GlaxoSmithKline?
GlaxoSmithKline trades on the New York Stock Exchange (NYSE) under the ticker symbol "GSK." How do I buy shares of GlaxoSmithKline? Shares of GSK can be purchased through any online brokerage account.
Is GlaxoSmithKline a great dividend payout stock?
GlaxoSmithKline is a leading dividend payer. It pays a dividend yield of 4.67%, putting its dividend yield in the top 25% of dividend-paying stocks. GlaxoSmithKline has only been increasing its dividend for 1 years. The dividend payout ratio of GlaxoSmithKline is 87.29%.
What is the target price for Glaukos Corp?
GKOS: Raising target price to $46.00 GLAUKOS CORP has an Investment Rating of HOLD; a target price of $46.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of High.
See more
When will GSK earnings call end?
Who is the CEO of GlaxoSmithKline?
GSK earnings call for the period ending September 30, 2021.
Is GlaxoSmithKline a pharmaceutical company?
Amid an assault from activist investors, GlaxoSmithKline CEO Emma Walmsley said the company's third-quarter financial results show that her strategy is on the right track.
